Rupatadine D4 | CAS 1795153-62-6 - Request Quote
Rupatadine D4
| SZ CAT No: | SZ-R026D02 |
| CAS No | 1795153-62-6 |
| Mol.F. | C26H22D4ClN3 |
| Mol.Wt. | 420.0 |
| Inv. Status | Under QC Approval |
| Rel. CAS No | 1795153-63-7 (fuarate salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rupatadine D4 is chemically 8-chloro-11-(1-((5-methylpyridin-3-yl)methyl)piperidin-4-ylidene-2,2,6,6-d4)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine. Rupatadine D4 is supplied with detailed characterization data compliant with regulatory guideline. Rupatadine D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rupatadine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1795153-62-6
Purchase 1795153-62-6
Order 1795153-62-6
Enquire 1795153-62-6
price of 1795153-62-6
1795153-62-6 Supplier
1795153-62-6 Manufacturer
1795153-62-6 Exporter
buy high quality Rupatadine D4
Purchase Rupatadine D4
Rupatadine D4 suppliers
Rupatadine D4 manufacturers
Rupatadine D4 price
Order Rupatadine D4
Enquire Rupatadine D4
Rupatadine D4 cost
Rupatadine D4 Supplier
Rupatadine D4 Distributor
Rupatadine D4 for Method Validation
Rupatadine Reference Standard
Rupatadine D4 for ANDA Filing
Rupatadine D4 for Forced Degradation Studies
Rupatadine D4 Identification Standards
Rupatadine D4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


